Literature DB >> 7483781

Development of an alternative method for testing the immunogenicity of diphtheria vaccines.

M A Manghi1, M F Pasetti, M L Brero, S Deluchi, G di Paola, V Mathet, P V Eriksson.   

Abstract

The immunogenicity of the diphtheria component of 73 commercial vaccines from five different manufacturers was tested by the toxin neutralization test (TNT) and the enzyme-linked immunosorbent assay (ELISA) developed in our laboratory. A comparison of the antibody levels measured by both assays showed a very good correlation (r = 0.95, p < 0.001). The results suggest that the proposed ELISA is a reliable, simple and economical alternative to the TNT in guinea pigs. Also, the ELISA was found to measure IgG antibody levels as low as 5.5 x 10(-5) IU ml-1. To evaluate the possibility of accelerating the active immunization during the activity test of vaccines, an alternative schedule using one single human dose was assayed. A very good correlation was observed between the IgG antibody response obtained with this schedule and with the traditional programme. Therefore, the cost and the time required to perform the activity test may be considerably reduced when both the rapid immunization schedule and the ELISA are used.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483781     DOI: 10.1016/0264-410x(94)00047-q

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.

Authors:  Pavan Muttil; Brian Pulliam; Lucila Garcia-Contreras; John Kevin Fallon; Chenchen Wang; Anthony James Hickey; David A Edwards
Journal:  AAPS J       Date:  2010-09-28       Impact factor: 4.009

2.  Re: M. G. Bergeron, M. Ouellette--diagnosing bacterial infectious diseases in one hour: an essential upcoming revolution (infection 23 [1995] 69-72)

Authors:  S C Arya
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

3.  Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.

Authors:  M Pasetti; P Eriksson; F Ferrero; M Manghi
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.